CENPL and breast carcinoma: DiseaseMeth version 2.0 analysis displayed that the mean methylation levels of CENPL, MRPL3 and LSM4 were all significantly reduced in breast cancer compared to normal breast tissues (P < 0.05) (Fig. 4a,c,d).